Literature DB >> 28533714

microRNAs in ischaemic cardiovascular diseases.

Simona Greco1, Germana Zaccagnini1, Christine Voellenkle1, Fabio Martelli1.   

Abstract

microRNAs (miRNAs) are non-coding RNA molecules that modulate the stability and/or the translational efficiency of specific messenger RNAs. They have been shown to play a regulatory role in most biological processes and their expression is disrupted in many cardiovascular diseases. This review describes studies performed at Policlinico San Donato-IRCCS in cell cultures, animal models, and patients, showing a penetrant role of miRNAs in cell response to hypoxia and in ischaemic cardiovascular diseases. These experiments indicate miRNA as an emerging class of therapeutic targets.

Entities:  

Keywords:  Cardiovascular diseases; Hypoxia; Ischaemia; microRNA

Year:  2016        PMID: 28533714     DOI: 10.1093/eurheartj/suw012

Source DB:  PubMed          Journal:  Eur Heart J Suppl        ISSN: 1520-765X            Impact factor:   1.803


  58 in total

Review 1.  Muscle injuries and repair: current trends in research.

Authors:  Johnny Huard; Yong Li; Freddie H Fu
Journal:  J Bone Joint Surg Am       Date:  2002-05       Impact factor: 5.284

2.  Deep-sequencing of endothelial cells exposed to hypoxia reveals the complexity of known and novel microRNAs.

Authors:  Christine Voellenkle; Jeroen van Rooij; Alessandro Guffanti; Elena Brini; Pasquale Fasanaro; Eleonora Isaia; Larry Croft; Matei David; Maurizio C Capogrossi; Anna Moles; Armando Felsani; Fabio Martelli
Journal:  RNA       Date:  2012-01-26       Impact factor: 4.942

3.  MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway.

Authors:  Zhenwei Pan; Xuelin Sun; Hongli Shan; Ning Wang; Jinghao Wang; Jinshuai Ren; Shuya Feng; Liangjun Xie; Chunying Lu; Ye Yuan; Yang Zhang; Ying Wang; Yanjie Lu; Baofeng Yang
Journal:  Circulation       Date:  2012-07-18       Impact factor: 29.690

Review 4.  MicroRNAs in heart failure: is the picture becoming less miRky?

Authors:  Yonathan F Melman; Ravi Shah; Saumya Das
Journal:  Circ Heart Fail       Date:  2014-01       Impact factor: 8.790

Review 5.  Pervasive roles of microRNAs in cardiovascular biology.

Authors:  Eric M Small; Eric N Olson
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

6.  Surgical ventricular restoration to reverse left ventricular remodeling.

Authors:  Serenella Castelvecchio; Lorenzo Menicanti; Marisa Di Donato
Journal:  Curr Cardiol Rev       Date:  2010-02

Review 7.  microRNA: emerging therapeutic targets in acute ischemic diseases.

Authors:  Pasquale Fasanaro; Simona Greco; Mircea Ivan; Maurizio C Capogrossi; Fabio Martelli
Journal:  Pharmacol Ther       Date:  2009-11-06       Impact factor: 12.310

8.  MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.

Authors:  Angelika Bonauer; Guillaume Carmona; Masayoshi Iwasaki; Marina Mione; Masamichi Koyanagi; Ariane Fischer; Jana Burchfield; Henrik Fox; Carmen Doebele; Kisho Ohtani; Emmanouil Chavakis; Michael Potente; Marc Tjwa; Carmen Urbich; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Science       Date:  2009-05-21       Impact factor: 47.728

9.  MicroRNA miR-1 is up-regulated in remote myocardium in patients with myocardial infarction.

Authors:  E Bostjancic; N Zidar; D Stajner; D Glavac
Journal:  Folia Biol (Praha)       Date:  2010       Impact factor: 0.906

10.  CTGF increases vascular endothelial growth factor-dependent angiogenesis in human synovial fibroblasts by increasing miR-210 expression.

Authors:  S-C Liu; S-M Chuang; C-J Hsu; C-H Tsai; S-W Wang; C-H Tang
Journal:  Cell Death Dis       Date:  2014-10-23       Impact factor: 8.469

View more
  3 in total

Review 1.  Role of miRNAs in hypoxia-related disorders.

Authors:  A Gupta; R Sugadev; Y K Sharma; Y Yahmad; P Khurana
Journal:  J Biosci       Date:  2018-09       Impact factor: 1.826

2.  MicroRNA-369 attenuates hypoxia-induced cardiomyocyte apoptosis and inflammation via targeting TRPV3.

Authors:  Jinghao Wang; Xu Chen; Wei Huang
Journal:  Braz J Med Biol Res       Date:  2021-01-15       Impact factor: 2.590

3.  miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice.

Authors:  Xiaoping Hu; Huagang Liu; Zhiwei Wang; Zhipeng Hu; Luocheng Li
Journal:  Oxid Med Cell Longev       Date:  2019-11-03       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.